The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Castle Biosciences Inc shares valued at $207,217 were sold by Stokes Frank on Nov 15 ’24. At $29.93 per share, Stokes Frank sold 6,923 shares. The insider’s holdings dropped to 30,823 shares worth approximately $0.94 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MAETZOLD DEREK J sold 3,155 shares, netting a total of over 107,743 in proceeds. Following the sale of shares at $34.15 each, the insider now holds 6,151 shares.
Before that, MAETZOLD DEREK J had sold 1,972 shares from its account. In a trade valued at $67,344, the Pres. & Chief Exec. Officer traded Castle Biosciences Inc shares for $34.15 each. Upon closing the transaction, the insider’s holdings decreased to 1,972 shares, worth approximately $2.67 million.
As published in their initiating research note from Guggenheim on December 14, 2023, Castle Biosciences Inc [CSTL] has been a Buy and the price target has been revised to $25. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early January. As of January 07, 2022, Stephens has initiated its “an Overweight” rating for CSTL. Earlier on April 30, 2021, Lake Street initiated its rating. Their recommendation was “a Buy” for CSTL stock.
Analyzing CSTL Stock Performance
During the last five days, there has been a surge of approximately 6.99%. Over the course of the year, Castle Biosciences Inc shares have jumped approximately 41.06%. Shares of the company reached a 52-week high of $35.84 on 11/05/24 and a 52-week low of $16.97 on 07/05/24. A 50-day SMA is recorded $30.94, while a 200-day SMA reached $25.10. Nevertheless, trading volume fell to 0.14 million shares from 0.27 million shares the previous day.
Support And Resistance Levels for Castle Biosciences Inc (CSTL)
According to the 24-hour chart, there is a support level at 30.08, which, if violated, would cause prices to drop to 29.73. In the upper region, resistance lies at 30.99. The next price resistance is at 31.55. RSI (Relative Strength Index) is 48.45 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.18, which suggests the price will decrease in the coming days. Percent R is at 56.76%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
